Skip to content
← Enterprise AI

CascadeMindBeta

Multi-Scale Mechanistic Intelligence

Trace how perturbations propagate from gene to environment — competing mechanisms, evidence tags, blind spots, and the assay that would settle it.

Who it's forTranslational Researchers · Clinician-Scientists · Biotech R&D

Two researchers at a lab bench, working together at a laptop among glassware and a microscope

What it does

  1. Multi-scale systems maps
  2. Hypothesis ledger (2–4 mechanisms)
  3. Evidence tagging
  4. Discriminating-test design

Built for

  1. Pharmacogenomics
  2. Biomarker interpretation
  3. Non-response analysis
  4. Hypothesis critique

Value

  1. No invented citations
  2. Parametric reasoning only
  3. Safety guardrails
  4. Population & scale caveats

How work changes

Same desk. Different first pass.

Traditional

Every page, every identifier, by hand.

  1. Out

    Literature silos by scale

  2. Out

    Single-mechanism narratives

  3. Out

    Correlation mistaken for causation

  4. Out

    Missing compensatory loops

  5. Out

    Unclear next experiment

  6. Out

    Slow hypothesis revision

CascadeMind

The model takes the first pass. People take the exceptions.

  1. Out

    Frame perturbed node & context

  2. Out

    Map cross-scale propagation

  3. Out

    Hold competing hypotheses

  4. Out

    Stress-test causality & population

  5. Out

    Rank with discriminating tests

  6. Out

    Flag blind spots & safety limits

Single-story mechanism explanationsRanked hypotheses with tests that could falsify each

Used for

Why X causes Y

Causal chains from molecular perturbation to clinical phenotype with feedback loops and scale gaps flagged.

Biomarker patterns

Explain discordant labs or omics signatures — what each pattern predicts and what would distinguish drivers from consequences.

Subgroup non-response

Competing mechanisms for treatment failure with pharmacogenomic, sex, and ancestry blind spots surfaced.